Expanding the armory of anti-viral approaches

Whilst the news is, finally, full of promising updates on vaccines, the world will need a wide range of prophylactic and therapeutic approaches to defeat the coronavirus.

Transformational year for Biocomposites

Against the backdrop of the pandemic and Brexit, Biocomposites’ lead product STIMULAN became the first calcium matrix to receive European approval as an antibiotic carrier for use in bone and soft-tissue.

‘Stick to the plan and listen to your investors’ 

Fireside Chat: ‘Communicating to investors through a crisis’ Chaired by Mary Clark, with Kevin Mannix, Head of IR at Teva, and Oliver Maier, Head of IR at Bayer 

© Optimum Strategic Communications.